Navigation Links
Elsevier Acquires Professional Development Software, Inc., Provider of 'Software for Nurses' Online Learning Education
Date:4/7/2009

ST. LOUIS, Missouri, April 7 /PRNewswire-FirstCall/ --

- Acquisition Extends the Evolve Testing and Remediation Product Suite

Elsevier, the leading global publisher of scientific, technical and medical information products and services, announced today the acquisition of the assets of Professional Development Software, Inc. (PDS), the provider of Softwarefornurses.com online learning education products. PDS will be integrated into Elsevier's Evolve Testing and Remediation product suite (which includes the 'HESI Test'), bringing additional content to Elsevier's total curriculum solution for nursing.

"PDS products are current, well-written, and very useful to nursing students and faculty seeking a review and remediation resource in preparing for the NCLEX(R)," said Sebastian Vos, Elsevier's Vice President for eLearning. "It is a perfect fit within the Evolve Testing and Remediation product suite."

For schools of nursing, PDS Software for Nurses modules are used for learning reinforcement, guidance in decision making, remediation, clinical make up and NCLEX(R) review. For healthcare organizations, the modules are used for orientation, competency testing, cross training, remediation, and continuing education.

PDS customers can continue to visit http://www.softwarefornurses.com for product information and any updates related to joining the Evolve Testing and Remediation product suite (http://www.evolve.elsevier.com). The suite comprises some of the best possible test preparation tools in the industry for both students and teachers, and is run by Elsevier, the world's leading and largest provider of medical content, tools and services. Terms of the agreement are not being disclosed.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult (http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/), bibliographic databases, and online reference works.

Elsevier (http://www.elsevier.com/) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Tom Reller, Director, Corporate Relations
    T.Reller@elsevier.com
    +1-212-462-1912


'/>"/>
SOURCE Elsevier
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Elsevier and Brain Mapping Foundation co-host 6th Annual World Congress of IBMISPS
2. Three Prize Winners Awarded in Elseviers Article 2.0 Contest
3. Elsevier Partners With Communispace to Launch Global Online Community
4. Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians
5. Elsevier Titles Win Four PROSE Awards From Association of American Publishers
6. Elsevier to launch over 600 health science e-Book titles on ScienceDirect
7. Elsevier to Launch Over 600 Health Science E-Book Titles on ScienceDirect
8. Elsevier Launches SciTopics, the Expert-Generated Information and Collaboration Web Resource
9. Elsevier Acquires William Andrew Publishing
10. The American College of Cardiology Renews its Publishing Partnership With Elsevier
11. Elsevier to Include Doyma Spanish Medical Collection Titles on ScienceDirect
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: